Ó£»¨ÊÓƵ

Skip to main content

Table 1 Clinical characteristics of participants included in the study

From: Association of waist-to-hip ratio adjusted for body mass index with cognitive impairment in middle-aged and elderly patients with type 2 diabetes mellitus: a cross-sectional study

Characteristic

Total (n = 1154)

Normal cognition (n = 645)

CI (²Ô = 509)

P value

Age, years

61.9 ±â¶Ä‰7.8

60.7 ±â¶Ä‰7.6

63.6 ±â¶Ä‰7.6

 &±ô³Ù; 0.001

Female, %

529 (45.8%)

278 (43.1%)

251 (49.3%)

0.035

Han nationality, %

1038 (89.9%)

584 (90.5%)

454 (89.2%)

0.148

Education, years

11 (9, 12)

12 (9, 12)

9 (9, 12)

 &±ô³Ù; 0.001

Current smoking status, %

357 (30.9%)

202 (31.3%)

155 (30.5%)

0.752

Current alcohol consumption status, %

313 (27.1%)

183 (28.4%)

130 (25.5%)

0.283

Physical exercise, %

819 (71.0%)

452 (70.1%)

367 (72.1%)

0.452

Nutrition management, %

760 (65.9%)

451 (69.9%)

309 (60.7%)

0.001

Cardiovascular disease, %

418 (36.2%)

222 (34.4%)

196 (38.5%)

0.151

Cerebrovascular disease, %

318 (27.6%)

140 (21.7%)

178 (35.0%)

 &±ô³Ù; 0.001

Hypertension, %

773 (67.0%)

419 (65%)

354 (69.5%)

0.100

Diabetes duration, years

7 (1, 13)

7 (1, 12)

8 (2, 14)

0.135

Antidiabetic agents, %

1023 (88.6%)

580 (89.9%)

443 (87%)

0.125

Metformin, %

522 (45.2%)

300 (46.5%)

222 (43.6%)

0.326

Insulin therapy, %

537 (46.5%)

298 (46.2%)

239 (47.0%)

0.799

Antihypertensive agents, %

669 (58.0%)

368 (57.1%)

301 (59.1%)

0.477

Lipid-lowering agents, %

131 (11.4%)

69 (10.7%)

62 (12.2%)

0.430

FPG, mmol/L

8.08 (6.53, 10.14)

8.09 (6.59, 10.24)

8.08 (6.53, 10.05)

0.482

TC, mmol/L

4.81 (4.14, 5.56)

4.85 (4.19, 5.57)

4.79 (4.10, 5.54)

0.256

TG, mmol/L

1.56 (1.14, 2.29)

1.62 (1.15, 2.38)

1.51 (1.13, 2.14)

0.056

HDL-c, mmol/L

1.16 (1.01, 1.34)

1.16 (1.02, 1.35)

1.15 (1.00, 1.32)

0.266

LDL-c, mmol/L

3.00 (2.49, 3.52)

3.03 (2.51, 3.57)

2.93 (2.42, 3.47)

0.068

UA, umol/L

290.5 (242.0, 347.0)

291.9 (237.3, 343.0)

289.1 (246.0, 358.0)

0.151

HbA1c, %

8.5 (7.3, 10.3)

8.5 (7.3, 10.4)

8.5 (7.2, 10.2)

0.677

SBP, mmHg

132.90 ±â¶Ä‰13.70

132.63 ±â¶Ä‰14.20

133.24 ±â¶Ä‰13.06

0.453

DBP, mmHg

79.33 ±â¶Ä‰8.60

79.31 ±â¶Ä‰8.59

79.36 ±â¶Ä‰8.63

0.933

BMI, kg/m2

26.17 ±â¶Ä‰5.53

26.30 ±â¶Ä‰3.63

26.00 ±â¶Ä‰3.39

0.152

WC, cm

91.5 ±â¶Ä‰9.6

90.8 ±â¶Ä‰9.8

92.3 ±â¶Ä‰9.3

0.007

WHRadjBMI

0.000 ±â¶Ä‰0.0629

-0.0127 ±â¶Ä‰0.0596

0.0160 ±â¶Ä‰0.0634

 &±ô³Ù; 0.001

MoCA scores

26 (24, 27)

27 (26, 28)

24 (22, 25)

 &±ô³Ù; 0.001

  1. Data is presented as mea²Ô ± standard deviation (SD) or median (25th, 75th percentile) or n (%)
  2. Abbreviations: FPG Fasting plasma glucose, TC Total cholesterol, TG Triglycerides, HDL-c High-density lipoprotein cholesterol, LDL-c Low-density lipoprotein cholesterol, UA Uric acid, HbA1c Glycated hemoglobin, SBP Systolic blood pressure, DBP Diastolic blood pressure, BMI Body mass index, WC Waist circumference, WHRadjBMI Waist-to-hip ratio adjusted for body mass index, MoCA Montreal Cognitive Assessment